S&P TSX Capped Composite...

US Dollar vs CAD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

DNLI Denali Therapeutics Inc

23.33

0.00 (0.00%)

Pre Market

Last Updated: 03:00:11

Delayed by 15 minutes

Annual Report to Security Holders (ars)

This regulatory filing also includes additional resources:
fy22denaliannualreport.pdf

Denali Therapeutics (NASDAQ:DNLI)
Historical Stock Chart
From Jun 2024 to Jul 2024

Click Here for more Denali Therapeutics Charts.

Denali Therapeutics (NASDAQ:DNLI)
Historical Stock Chart
From Jul 2023 to Jul 2024

Click Here for more Denali Therapeutics Charts.

Denali Therapeutics Inc. News

Form 4 - Statement of changes in beneficial ownership of securities
Monday 10 June 2024 (1 month ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Thursday 6 June 2024 (1 month ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 4 June 2024 (1 month ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 4 June 2024 (1 month ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 4 June 2024 (1 month ago) • Edgar (US Regulatory)

Denali Therapeutics Announces FDA Has Selected DNL126 (ETV:SGSH) for MPS IIIA (Sanfilippo Syndrome Type A) for START Pilot Program Intended to Accelerate Development of Rare Disease Therapies
Monday 3 June 2024 (1 month ago) • GlobeNewswire Inc.

Form 8-K - Current report
Friday 31 May 2024 (1 month ago) • Edgar (US Regulatory)

Form 8-K - Current report
Tuesday 7 May 2024 (2 months ago) • Edgar (US Regulatory)

Denali Therapeutics Reports First Quarter 2024 Financial Results and Business Highlights
Tuesday 7 May 2024 (2 months ago) • GlobeNewswire Inc.

Denali Therapeutics Announces Completion of Enrollment for Regimen G Evaluating eIF2B Agonist DNL343 in the Phase 2/3 HEALEY ALS Platform Trial
Wednesday 1 May 2024 (2 months ago) • GlobeNewswire Inc.

Form D - Notice of Exempt Offering of Securities
Friday 1 March 2024 (4 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Tuesday 27 February 2024 (5 months ago) • Edgar (US Regulatory)

More Denali Therapeutics Inc. News Articles

Charter Communications

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions